Focus-X Therapeutics
ExitedPreclinical stage biotechnology company committed to the discovery and development of cutting-edge radiopharmaceuticals.
New Jersey, United StatesFocus-X Therapeutics ↗
Total raised
€0
€0
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Nov 2022
Value
€237M
Acquiror
Full-Life Technologies (Belgium)
Related news
- Full-Life Technologies to Acquire Focus-X Therapeutics, for Up To $245Mfinsmes.com · 2022-11
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce